How would you measure the success of Evernorth's SafeGuardRx program?

Introduction

Measuring the success of Evernorth's SafeGuardRx program requires a comprehensive approach that considers multiple stakeholders and metrics. This innovative program aims to improve patient outcomes and reduce healthcare costs through targeted interventions and specialized care management. To effectively evaluate its performance, we'll need to consider a range of factors, from clinical outcomes to financial impact and patient satisfaction.

Step 1

Product Context

SafeGuardRx is a value-based program offered by Evernorth, a health services company under Cigna. It focuses on managing complex and costly health conditions through specialized care and innovative drug therapies. The program targets conditions such as diabetes, inflammatory diseases, and multiple sclerosis.

Key stakeholders include:

1. Patients: Seeking improved health outcomes and reduced out-of-pocket costs
2. Healthcare providers: Looking for better patient outcomes and streamlined care delivery
3. Employers/Plan sponsors: Aiming to reduce healthcare costs while improving employee health
4. Pharmaceutical companies: Interested in demonstrating the value of their therapies
5. Evernorth/Cigna: Seeking to differentiate their offerings and improve overall healthcare value

User flow:

1. Patient enrollment: Eligible patients are identified and enrolled in the program
2. Assessment: Comprehensive evaluation of patient's condition and needs
3. Care plan development: Tailored interventions and medication regimens are created
4. Ongoing management: Regular check-ins, medication adjustments, and support services
5. Outcomes tracking: Continuous monitoring of clinical and financial outcomes

SafeGuardRx fits into Evernorth's broader strategy of providing innovative, value-based healthcare solutions that improve outcomes while managing costs. It differentiates Evernorth from traditional pharmacy benefit managers by offering a more holistic, condition-specific approach to care.

Compared to competitors like CVS Health's Transform Diabetes Care or Express Scripts' SafeGuardRx (before Cigna's acquisition), Evernorth's program offers a wider range of conditions and more integrated care management.

Product Lifecycle Stage: SafeGuardRx is in the growth stage, continuously expanding to cover new conditions and refining its approach based on data and outcomes.